Nektar TherapeuticsNKTR
那斯達克 · USD
22.96
+1.28
(+5.90%)
收盤 08/02 03:58 (UTC+8)
盤後
22.96
22.96
(-0.17%)
08/02 03:58 (UTC+8)
Nektar TherapeuticsNKTR
22.96
+1.28
(+5.90%)
財務數據
損益表
- 0.22
- 0.22
- 0.20
- 0.24
- 0.24
- 0.22
- 0.23
- 0.24
- 0.29
- 0.10
- -6.78
- -1.95
- -5.07
- 17.78
- -1.07
- -9.40
- 8.55
- 2.70
- 20.94
- -64.15
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 10,460 | 29,175 | 24,124 | 23,489 | 21,639 | 23,885 | 24,144 | 20,499 | 21,594 | 22,023 |
營業成本 | - | 7,977 | 4,435 | 9,740 | 8,534 | 7,283 | 12,431 | 6,994 | 7,060 | 6,233 |
營業毛利 | 10,460 | 21,198 | 19,689 | 13,749 | 13,105 | 16,602 | 11,713 | 13,505 | 14,534 | 15,790 |
營業費用 | 54,995 | 47,240 | 54,034 | 63,523 | 48,532 | 50,113 | 56,577 | 64,104 | 149,244 | 68,259 |
研發費用 | 30,480 | 28,745 | 35,031 | 29,724 | 27,408 | 29,942 | 24,070 | 29,681 | 30,469 | 34,740 |
推銷及管理費用 | 24,346 | 17,135 | 18,957 | 20,510 | 20,149 | 17,320 | 21,147 | 17,869 | 21,081 | 21,939 |
非經常性項目費用 | 169 | 1,360 | 46 | 13,289 | 975 | 2,851 | 11,360 | 16,554 | 97,694 | 11,580 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -44,535 | 14,348 | -34,345 | -49,774 | -35,427 | -33,511 | -44,864 | -50,599 | -134,710 | -52,469 |
其他收入及費用 | 3,140 | 43,197 | 3,317 | 3,865 | 4,121 | -1,730 | 4,876 | 5,582 | 4,034 | 3,126 |
利息費用 | 4,974 | 10,153 | 6,020 | 6,408 | 5,531 | 6,867 | 5,910 | 6,152 | 6,405 | 7,201 |
稅前純益 | -46,369 | 7,002 | -37,048 | -52,317 | -36,837 | -42,108 | -45,898 | -51,169 | -137,081 | -56,544 |
所得稅 | 52 | -259 | 9 | 46 | -35 | -29 | -61 | -47 | -63 | 3,144 |
稅後純益 | -50,882 | 7,261 | -37,057 | -52,363 | -36,802 | -42,079 | -45,837 | -51,122 | -137,018 | -59,688 |
基本每股稅後盈餘(元) | -0.24 | 0.03 | -0.18 | -0.25 | -0.19 | -0.22 | -0.24 | -0.27 | -0.73 | -0.32 |
稀釋每股稅後盈餘(元) | -0.24 | 0.04 | -0.18 | -0.25 | -0.19 | -0.22 | -0.24 | -0.26 | -0.73 | -0.32 |
基本平均股數(千股) | 210924.00 | 209737.00 | 209249.00 | 208828.00 | 194746.00 | 191040.00 | 190406.00 | 189656.00 | 188875.00 | 188237.00 |
稀釋平均股數(千股) | 210924.00 | 213593.00 | 209249.00 | 208828.00 | 194746.00 | 191040.00 | 190406.00 | 189656.00 | 188875.00 | 188237.00 |
還原基本每股稅後盈餘(元) | -3.60 | 0.45 | -2.70 | -3.75 | -2.85 | -3.30 | -3.60 | -4.05 | -10.95 | -4.80 |
還原稀釋每股稅後盈餘(元) | -3.60 | 0.60 | -2.70 | -3.75 | -2.85 | -3.30 | -3.60 | -3.90 | -10.95 | -4.80 |
還原基本平均股數(千股) | 14,062 | 13,983 | 13,950 | 13,922 | 12,983 | 12,736 | 12,694 | 12,644 | 12,592 | 12,549 |
還原稀釋平均股數(千股) | 14,062 | 14,240 | 13,950 | 13,922 | 12,983 | 12,736 | 12,694 | 12,644 | 12,592 | 12,549 |
EBITDA(千元) | -46,754 | 15,953 | -32,099 | -47,034 | -32,762 | -36,308 | -42,280 | -47,872 | -131,503 | -48,224 |